[n-(3-{bis[2-(pyridin-2-yl-kappan)ethyl]amino-kappan}propyl)-5-(2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanamide](azido)(hydroxy)copper

Grouped By: Sequence identity 70%

Group Content:

Explore Sequence Alignments in 3D

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.